Francis John Jr Hornicek
#144,322
Most Influential Person Now
Francis John Jr Hornicek's AcademicInfluence.com Rankings
Francis John Jr Hornicekphilosophy Degrees
Philosophy
#7693
World Rank
#10940
Historical Rank
Logic
#4732
World Rank
#6057
Historical Rank
Download Badge
Philosophy
Why Is Francis John Jr Hornicek Influential?
(Suggest an Edit or Addition)Francis John Jr Hornicek's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors (2012) (588)
- Percutaneous Radiofrequency Coagulation of Osteoid Osteoma Compared with Operative Treatment* (1998) (544)
- Osteoid osteoma: percutaneous treatment with radiofrequency energy. (2003) (486)
- Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. (2011) (439)
- Aneurysmal bone cyst: a review of 150 patients. (2005) (376)
- Factors Affecting Nonunion of the Allograft-Host Junction (2001) (299)
- EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. (2014) (296)
- A spatially and temporally restricted mouse model of soft tissue sarcoma (2007) (292)
- Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. (2001) (288)
- Treatment and Outcome of 82 Patients with Angiosarcoma (2007) (261)
- Effect of Nonsteroidal Antiinflammatory Drugs on Fracture Healing: A Laboratory Study in Rats (1995) (260)
- Solid stress and elastic energy as measures of tumour mechanopathology (2016) (238)
- MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration (2011) (238)
- Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. (2009) (235)
- Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions (2002) (214)
- Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. (2006) (209)
- Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. (2002) (203)
- Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas (2014) (188)
- Survivorship Analysis of 141 Modular Metallic Endoprostheses at Early Followup (2004) (186)
- Classification of failure of limb salvage after reconstructive surgery for bone tumours : a modified system Including biological and expandable reconstructions. (2014) (176)
- Programmed Cell Death Ligand 1 Expression in Osteosarcoma (2014) (171)
- Survival Data for 648 Patients with Osteosarcoma Treated at One Institution (2004) (164)
- Exosomes promote pre-metastatic niche formation in ovarian cancer (2019) (158)
- Radiation therapy for control of soft-tissue sarcomas resected with positive margins. (2005) (154)
- MicroRNA Involvement in Osteosarcoma (2012) (151)
- Infection in Massive Bone Allografts (2005) (151)
- Allografts about the Knee in Young Patients with High-Grade Sarcoma (2004) (149)
- Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma (2009) (146)
- NCCN Guidelines Insights: Bone Cancer, Version 2.2017. (2017) (143)
- Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group (2017) (141)
- Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma (2010) (134)
- Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma (2011) (130)
- Diagnosis, classification, and management of soft tissue sarcomas. (2005) (128)
- High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. (2015) (127)
- Comparison of Quality of Life After Amputation or Limb Salvage (2002) (116)
- Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. (1992) (116)
- MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer (2015) (115)
- Osteoblastoma: A 30‐year study of 99 cases (2008) (114)
- Survival Data for Patients with Malignant Schwannoma (2004) (113)
- Definitive High-Dose Photon/Proton Radiotherapy for Unresected Mobile Spine and Sacral Chordomas (2013) (112)
- Desmoid Tumor: Analysis of Prognostic Factors and Outcomes in a Surgical Series (2012) (106)
- Limb salvage with osteoarticular allografts after resection of proximal tibia bone tumors. (1998) (104)
- Value of PET in the assessment of patients with neurofibromatosis type 1. (2007) (103)
- β-Catenin mutation status and outcomes in sporadic desmoid tumors. (2013) (103)
- Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer (2015) (102)
- Long-Term Followup of Proximal Femoral Allografts (2002) (102)
- Distal Lower Extremity Sarcomas: Frequency of Occurrence and Patient Survival Rate (2004) (102)
- Bone cancer, version 2.2017 featured updates to the NCCN guidelines (2017) (101)
- Giant Cell Tumor of Bone (2013) (100)
- Small-molecule targeting of brachyury transcription factor addiction in chordoma (2019) (98)
- Prognostic Factors and Outcomes of Patients with Myxofibrosarcoma (2012) (98)
- Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas (2011) (96)
- Advances in immune checkpoint inhibitors for bone sarcoma therapy (2019) (96)
- Outcome After Reconstruction of the Proximal Humerus for Tumor Resection: A Systematic Review (2014) (96)
- Evidence that adenosine 3',5'-monophosphate mediates stimulation of thyroid growth in FRTL5 cells. (1986) (92)
- Effects of Siltuximab on the IL-6–Induced Signaling Pathway in Ovarian Cancer (2010) (90)
- Pigmented villonodular synovitis of joints (2011) (89)
- Development of a Prognostic Survival Algorithm for Patients with Metastatic Spine Disease. (2016) (89)
- Unicameral Bone Cyst: A Retrospective Study of Three Surgical Treatments (2008) (89)
- Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA‐1 in Met expression (2010) (88)
- Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer. (2016) (88)
- Clinicopathologic characteristics of poorly differentiated chordoma (2018) (84)
- Extra‐abdominal desmoid tumors: A report of 234 cases (2010) (84)
- Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma (2015) (83)
- Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines (2009) (81)
- Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations (2013) (81)
- Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone (2016) (79)
- ROCK1 as a potential therapeutic target in osteosarcoma (2011) (79)
- Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma (2009) (77)
- Clear cell sarcoma of soft tissues (2007) (76)
- Paget’s Sarcoma: A Historical and Outcome Review (2005) (75)
- RNA sequencing (RNA-Seq) and its application in ovarian cancer. (2019) (73)
- Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer (2015) (72)
- Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. (2011) (72)
- Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1 (2014) (72)
- Leiomyosarcoma of Somatic Soft Tissues (2004) (71)
- Massive distal femoral osteoarticular allografts after resection of bone tumors. (1994) (71)
- Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated‐Stat3 correlates with poor prognosis (2010) (71)
- Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. (2003) (71)
- Rhabdomyosarcoma: Advances in Molecular and Cellular Biology (2015) (70)
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells (2009) (70)
- Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy. (2017) (68)
- Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. (2013) (68)
- Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas (2009) (67)
- CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma (2015) (67)
- Surgical Treatment of Hemangiomas of Soft Tissue (2002) (66)
- Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. (2013) (64)
- Prognostic significance of treatment‐induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy (2014) (63)
- Chondrosarcoma of the Mobile Spine: A Review of 21 Cases Treated at a Single Center (2010) (63)
- High‐throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide‐3‐kinase and other oncogenes (2012) (63)
- Chondromyxoid Fibroma: A Rarely Encountered and Puzzling Tumor (2005) (62)
- Facial Layer-by-Layer Engineering of Upconversion Nanoparticles for Gene Delivery: Near-Infrared-Initiated Fluorescence Resonance Energy Transfer Tracking and Overcoming Drug Resistance in Ovarian Cancer. (2017) (62)
- Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells (2017) (61)
- Primary Sclerosing Epithelioid Fibrosarcoma of Bone: Analysis of a Series (2014) (61)
- Long‐term follow‐up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas (2012) (59)
- Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone. (2008) (59)
- 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates? (2015) (58)
- Soft Tissue Sarcoma Resection Volume Associated with Wound-healing Complications (2007) (58)
- Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation (2012) (58)
- The Effect of Adjuvant Chemotherapy on Osteoarticular Allografts (2001) (57)
- Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system (2015) (57)
- Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma (2018) (57)
- A novel target for treatment of chordoma: signal transducers and activators of transcription 3 (2009) (57)
- Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance (2016) (56)
- Treatment of Giant Cell Tumors with Allograft Transplants: A 30-year Study (2005) (56)
- Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas (2009) (55)
- Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma. (2009) (55)
- Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. (2010) (55)
- Primary Myoepithelioma of Bone: A Report of 8 Cases (2013) (53)
- Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital. (2010) (50)
- Regulation of microRNAs function by circular RNAs in human cancer (2017) (50)
- Total Femur Replacement Procedures in Tumor Treatment (2005) (49)
- Characteristics and Patterns of Metastatic Disease from Chordoma (2015) (49)
- The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer (2016) (49)
- Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway (2010) (49)
- Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential (2016) (48)
- The role of extracelluar matrix in osteosarcoma progression and metastasis (2020) (48)
- Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy. (2020) (48)
- MRI surveillance following treatment of extremity soft tissue sarcoma (2014) (48)
- The kinase Mirk is a potential therapeutic target in osteosarcoma. (2010) (48)
- Intraoperative dural irradiation by customized 192iridium and 90yttrium brachytherapy plaques. (2003) (47)
- Malignant transformation of synovial chondromatosis of the shoulder to chondrosarcoma. A case report. (2007) (47)
- NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance (2009) (47)
- Therapeutic applications of histone deacetylase inhibitors in sarcoma. (2017) (46)
- From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma (2018) (46)
- Anterior Spinal Arthrodesis With Structural Cortical Allografts and Instrumentation for Spine Tumor Surgery (2004) (46)
- MicroRNA‐1 (miR‐1) inhibits chordoma cell migration and invasion by targeting slug (2014) (46)
- An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. (2010) (46)
- Spinal Cord Blood Supply and Its Surgical Implications (2015) (46)
- Malignant Tumors of the Pelvis: An Outcome Study (2004) (46)
- How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function? (2016) (46)
- Results of radiation therapy performed after unplanned surgery (without re‐excision) for soft tissue sarcomas (2005) (45)
- Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma (2015) (45)
- Malignant Lymphoma of Bone: A Review of 119 Patients (2013) (45)
- The Vertical and Extended Rectus Abdominis Myocutaneous Flap for Irradiated Thigh and Groin Defects (2008) (44)
- Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925 (2014) (44)
- Chordoma: an update on the pathophysiology and molecular mechanisms (2015) (44)
- Tissue Microarray Immunohistochemical Detection of Brachyury Is Not a Prognostic Indicator in Chordoma (2013) (44)
- Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro (2016) (43)
- Effects of γ-interferon and tumor necrosis factor α on thyroid cells: induction of class II antigen and inhibition of growth stimulation (1988) (43)
- Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells. (2014) (43)
- How Does the Level of Nerve Root Resection in En Bloc Sacrectomy Influence Patient-Reported Outcomes? (2017) (43)
- Prognostic significance of miRNA‐1 (miR‐1) expression in patients with chordoma (2014) (43)
- Modified En Bloc Spondylectomy for Tumors of the Thoracic and Lumbar Spine: Surgical Technique and Outcomes (2017) (42)
- Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery (2016) (42)
- Complications and reoperations after surgery for 647 patients with spine metastatic disease. (2019) (42)
- miR‐15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo (2016) (42)
- P-Glycoprotein Levels Predict Poor Outcome in Patients With Osteosarcoma (2000) (41)
- Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer. (2012) (41)
- Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST. (2019) (41)
- Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution. (2019) (41)
- Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma. (2018) (41)
- Complications and Risk Factors for Failure of Rotationplasty: Review of 25 Patients (2008) (41)
- Synovial Chondromatosis of the Foot (2004) (41)
- Prognostic factors in alveolar soft part sarcoma: A SEER analysis (2016) (40)
- Expression and Therapeutic Potential of SOX9 in Chordoma (2017) (40)
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells (2011) (40)
- Blockage of Stat3 With CDDO-Me Inhibits Tumor Cell Growth in Chordoma (2010) (40)
- The Width of the Surgical Margin Does Not Influence Outcomes in Extremity and Truncal Soft Tissue Sarcoma Treated With Radiotherapy. (2016) (39)
- Validation of the Spine Oncology Study Group-Outcomes Questionnaire to assess quality of life in patients with metastatic spine disease. (2017) (39)
- Lipid-functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot Study (2013) (39)
- Internal hemipelvectomy for the management of pelvic sarcomas. (2005) (39)
- Targeting hedgehog‐GLI‐2 pathway in osteosarcoma (2013) (39)
- Decreasing length of hospital stay in treatment of osteoid osteoma. (1999) (38)
- MicroRNA-155 expression is independently predictive of outcome in chordoma (2015) (38)
- Establishment and characterization of a novel chordoma cell line: CH22 (2012) (38)
- Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications. (2019) (37)
- Osteoid osteoma: elevation of cardiac and respiratory rates at biopsy needle entry into tumor in 10 patients. (2003) (37)
- Management of acral myxoinflammatory fibroblastic sarcoma (2010) (37)
- Improved survival for sarcomas of the wrist and hand. (2006) (36)
- Complications After Surgical Management of Proximal Femoral Metastasis: A Retrospective Study of 417 Patients (2016) (36)
- Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma (2020) (36)
- Near-infrared light activated delivery platform for cancer therapy. (2015) (36)
- Most efficient questionnaires to measure quality of life, physical function, and pain in patients with metastatic spine disease: a cross-sectional prospective survey study. (2017) (36)
- The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. (2019) (36)
- Osteoarticular and Total Elbow Allograft Reconstruction With Severe Bone Loss (2008) (36)
- Ecteinascidin-743 drug resistance in sarcoma cells: transcriptional and cellular alterations. (2003) (35)
- PTEN in osteosarcoma: Recent advances and the therapeutic potential. (2020) (35)
- Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma (2019) (35)
- Characterization and Analysis of Human Chordoma Cell Lines (2010) (35)
- Quality of life after en bloc resection of tumors in the mobile spine. (2015) (35)
- Regulation of microRNA-1 (miR-1) expression in human cancer. (2017) (34)
- Application of liquid biopsy in bone and soft tissue sarcomas: Present and future. (2018) (34)
- Outcome after fixation of metastatic proximal femoral fractures: A systematic review of 40 studies (2016) (34)
- Role of post‐operative radiation boost for soft tissue sarcomas with positive margins following pre‐operative radiation and surgery (2014) (32)
- Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets (2017) (32)
- Current treatment strategy for newly diagnosed chordoma of the mobile spine and sacrum: results of an international survey. (2019) (32)
- BRAF mutation in ‘sarcomas’: a possible method to detect de‐differentiated melanomas (2014) (32)
- Alveolar Soft Part Sarcoma: A Rare and Enigmatic Entity (2005) (31)
- The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma (2016) (31)
- The roles and implications of exosomes in sarcoma (2016) (31)
- p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines (2016) (31)
- CSPG4 as a prognostic biomarker in chordoma. (2016) (30)
- Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer (2008) (30)
- Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications. (2018) (30)
- Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells (2015) (30)
- Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma (2019) (29)
- Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743. (2005) (29)
- The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases (2016) (29)
- Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss (2017) (29)
- A comparison of questionnaires for assessing physical function in patients with lower extremity bone metastases (2016) (29)
- What Factors are Associated With Quality Of Life, Pain Interference, Anxiety, and Depression in Patients With Metastatic Bone Disease? (2017) (29)
- Surgical site infection in orthopaedic oncology. (2014) (28)
- Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel (2016) (28)
- An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets (2017) (28)
- Multidrug Resistance Reversal Agent, NSC77037, Identified with a Cell-Based Screening Assay (2010) (27)
- Advances in sarcoma gene mutations and therapeutic targets. (2018) (27)
- Cyclin G–Associated Kinase Is Necessary for Osteosarcoma Cell Proliferation and Receptor Trafficking (2010) (27)
- Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma (2018) (27)
- CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells (2018) (27)
- Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo (2011) (26)
- Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma. (2016) (26)
- Clinical Outcome in Chordoma: Utility of Flow Cytometry in DNA Determination (2002) (26)
- Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large extremity soft tissue sarcomas. (2010) (26)
- Monostotic fibrous dysplasia of the spine: a report of seven cases. (2010) (25)
- Use of bisphosphonates in orthopedic surgery: pearls and pitfalls. (2014) (25)
- Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer. (2018) (24)
- Vascularized Fibular Strut Autografts in Spinal Reconstruction after Resection of Vertebral Chordoma or Chondrosarcoma: A Retrospective Series (2017) (24)
- Maxillofacial and axial/appendicular giant cell lesions: unique tumors or variants of the same disease?--A comparison of phenotypic, clinical, and radiographic characteristics. (2010) (24)
- The Roles of Sox Family Genes in Sarcoma. (2016) (24)
- Locking Versus Standard Plates for Allograft Fixation After Tumor Resection in Children and Adolescents (2006) (23)
- Three-dimensional (3D) culture in sarcoma research and the clinical significance (2017) (23)
- NVP‐TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P‐glycoprotein (PGP1) function (2016) (22)
- High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients (2018) (22)
- The stability of the hip after the use of a proximal femoral endoprosthesis for oncological indications: ANALYSIS OF VARIABLES RELATING TO THE PATIENT AND THE SURGICAL TECHNIQUE (2017) (22)
- Synergistic Effects of Targeted PI3K Signaling Inhibition and Chemotherapy in Liposarcoma (2014) (22)
- What's new in primary bone tumors. (2012) (22)
- Cancer Testis Antigens in Sarcoma: Expression, Function and Immunotherapeutic Application. (2020) (22)
- Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45α expression (2008) (22)
- Metastasectomy, intralesional resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma (2016) (22)
- Targeting protein kinases to reverse multidrug resistance in sarcoma. (2016) (22)
- Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution (2019) (21)
- Treatment of proximal humeral chondrosarcoma with resection and allograft. (2007) (21)
- A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells (2014) (21)
- Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P‐glycoprotein and enhancing apoptosis (2015) (21)
- Cytomorphologic features that distinguish schwannoma from other low‐grade spindle cell lesions (2015) (21)
- Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance. (2015) (20)
- Autophagy as a potential target for sarcoma treatment. (2017) (20)
- The Use of Flow Cytometry in Assessing Malignancy in Bone and Soft Tissue Tumors (2002) (20)
- Quality of life after resection of a chordoma of the mobile spine (2017) (20)
- Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines. (2011) (20)
- Functional Outcomes and Complications After Oncologic Reconstruction of the Proximal Humerus (2018) (19)
- Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines (2009) (19)
- Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma (2017) (19)
- Do histologic criteria predict biologic behavior of giant cell lesions? (2012) (19)
- Differences in sex distribution, anatomic location and MR imaging appearance of pediatric compared to adult chordomas (2016) (19)
- CDK4 expression in chordoma: A potential therapeutic target (2018) (18)
- HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1. (2018) (18)
- Chordoma arising from benign multifocal notochordal tumors (2017) (18)
- What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey. (2017) (18)
- Clinical and biological significance of PIM1 kinase in osteosarcoma (2016) (18)
- Outcome of operative treatment of metastatic fractures of the humerus: a systematic review of twenty three clinical studies (2015) (18)
- Allograft reconstruction in malignant bone tumors: indications and limits. (2009) (18)
- Functional and oncological outcome after surgical resection of the scapula and clavicle for primary chondrosarcoma (2017) (18)
- Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases? (2016) (17)
- Treatment of metastatic carcinoma to the hip with CT-guided percutaneous acetabuloplasty: report of four cases. (2009) (16)
- ZNF93 Increases Resistance to ET-743 (Trabectedin; Yondelis®) and PM00104 (Zalypsis®) in Human Cancer Cell Lines (2009) (16)
- What Is the Effect of High-dose Radiation on Bone in Patients With Sacral Chordoma? A CT Study (2018) (16)
- Aberrant DNA methylations in chondrosarcoma. (2016) (16)
- Updated external validation of the SORG machine learning algorithms for prediction of ninety-day and one-year mortality after surgery for spinal metastasis. (2021) (16)
- Percutaneous Acetabuloplasty Compared With Open Reconstruction for Extensive Periacetabular Carcinoma Metastases. (2015) (16)
- Paget Disease of Bone. (2015) (16)
- Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potential (2014) (16)
- Personalized chordoma organoids for drug discovery studies (2021) (16)
- Epithelioid Sarcoma With Heterotopic Bone: A Morphologic Review of 4 Cases (2010) (16)
- Complications after surgery for metastatic humeral lesions. (2016) (16)
- MDR 1 siRNA loaded hyaluronic acid-based CD 44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer (2015) (15)
- Lower Extremity Megaprostheses in Orthopaedic Oncology. (2018) (15)
- Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation (2021) (15)
- Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats (2016) (15)
- Alendronate inhibits growth of high-grade chondrosarcoma cells. (2009) (15)
- Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures? (2015) (15)
- RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines (2009) (14)
- Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma. (2011) (14)
- Effects of interferon‐gamma and tumour necrosis factor‐alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma (1991) (14)
- What Are the Functional Results and Complications From Allograft Reconstruction After Partial Hemipelvectomy of the Pubis? (2015) (14)
- Interaction of plasminogen-related protein B with endothelial and smooth muscle cells in vitro. (2003) (14)
- Primary intra‐articular sarcoma: a clinicopathological study of 15 cases (2016) (14)
- Evaluation of P‐glycoprotein (Pgp) expression in human osteosarcoma by high‐throughput tissue microarray (2016) (14)
- Control of alkaline phosphatase activity in C3H10T1/2 cells: Role of retinoic acid and cell density (1992) (14)
- Epithelioid hemangioma of the spine: a case series of six patients and review of the literature. (2013) (14)
- Long-term follow-up of custom cross-pin fixation of 56 tumour endoprosthesis stems: a single-institution experience. (2019) (13)
- Cytometric analysis of the proliferative capacity of HUT 102 lymphoblasts exposed to long-wave UV light and psoralen. (1989) (13)
- Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone (2017) (13)
- Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma. (2020) (13)
- [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine. (2014) (13)
- Dedifferentiated parosteal osteosarcoma with rhabdomyosarcomatous differentiation (1999) (13)
- Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma (2019) (13)
- Nanoparticles: A Promising Modality in the Treatment of Sarcomas (2011) (12)
- Ultrastructural modification of the plasma membrane in HUT 102 lymphoblasts by long-wave ultraviolet light, psoralen, and PUVA. (1990) (12)
- Up-regulation of CD 44 in the development of metastasis , recurrence and drug resistance of ovarian cancer (2015) (12)
- A Phase 1 Study of Nilotinib Plus Radiation in High-Risk Chordoma. (2018) (12)
- Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for Screening (2017) (12)
- Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue. (2014) (12)
- Fibromatosis: current strategies for treatment (2003) (11)
- Histologic variants of chondrosarcoma (2014) (11)
- A Review of DNA Flow Cytometric Preparatory and Analytical Methods (1985) (11)
- Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma (2020) (11)
- Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells (2017) (11)
- Sarcoidosis of the spine: a report of five cases and a review of the literature. (2012) (11)
- NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. (2015) (11)
- Extraskeletal osteosarcoma: A large series treated at a single institution (2018) (11)
- Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11 (2017) (11)
- What's new in primary bone tumors. (2012) (10)
- The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcoma. (2015) (10)
- Application of metabolomics in sarcoma: From biomarkers to therapeutic targets. (2017) (10)
- ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer (2020) (10)
- Tumor reconstruction. (1999) (10)
- Membranous lipodystrophy. A case report. (2002) (9)
- MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma (2019) (9)
- Management of metastatic humeral fractures: Variations according to orthopedic subspecialty, tumor characteristics. (2017) (9)
- Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas (2016) (9)
- Effects of gamma-interferon and tumor necrosis factor alpha on thyroid cells: induction of class II antigen and inhibition of growth stimulation. (1988) (9)
- Noncoding RNA in drug resistant sarcoma (2017) (9)
- Production and partial characterization of interleukin 2 induced by periodic acid oxidation of lymphocyte membranes. (1984) (8)
- T‐LAK cell‐originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma (2020) (8)
- Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation (2019) (8)
- Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma (2020) (8)
- Non-neoplastic soft tissue masses that mimic sarcoma. (2014) (8)
- The experience of accommodating privacy restrictions during implementation of a large‐scale surveillance study of an osteoporosis medication (2016) (8)
- Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067 (2020) (8)
- What's new in primary malignant musculoskeletal tumors. (2013) (8)
- Aberration of p73 Promoter Methylation in Chondrosarcoma. (2017) (7)
- Selective affinity of 8-methoxypsoralen for erythrocyte ghost proteins during UV-A irradiation (1986) (7)
- Synovial sarcoma of the shoulder: A series of 14 cases (2018) (7)
- Response of human chondrocytes cultured in vitro to human somatotropin, triiodothyronine, and thyroxine. (1997) (7)
- Oral and maxillofacial surgery; oncology: Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws (2003) (7)
- Upper-extremity infections in patients seropositive for human immunodeficiency virus. (1997) (7)
- Flow cytometry of blastogenesis and the concomitant viability assay of lymphocytes stained with 4', 6 diamidino-2-phenylindole. (1986) (7)
- Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777 (2019) (7)
- Turnover of phospholipids in HUT 102 lymphoblasts and chromatographic characterization of purified lecithins after their exposure to long-wave UV light, psoralen, and UV light and psoralen. (1992) (7)
- Pleomorphic spindle cell sarcoma (PSCS) formerly known as malignant fibrous histiocytoma (MFH): a complex malignant soft-tissue tumor (2012) (7)
- Latissimus dorsi flap closure of the irradiated clavicular wound. (2008) (6)
- Periodic acid-induced blastogenesis of lymphocytes is independent of phosphoinositide turnover. (1988) (6)
- The interaction of bisulfite and its free radical analog-nitroxyldisulfonate with periodic acid-oxidized lymphocytes and their effect on blastogenesis. (1985) (6)
- Genomic and epigenetic instability in chordoma: current insights (2014) (6)
- Genetic Analysis of Giant Cell Lesions of the Maxillofacial and Axial/Appendicular Skeletons. (2017) (6)
- Therapeutic Discovery MicroRNA-199 a-3 p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration (2011) (6)
- Noncoding RNA in drug resistant sarcoma. (2017) (6)
- Effect of Mitogens on the Cell Cycle Progression and the Quantification of T‐Lymphocyte Surface Markers in Acquired Immune Deficiency Syndrome (1987) (6)
- Nonmechanical Revision Indications Portend Certain Limb-Salvage Failure Following Total Femoral Replacement. (2020) (5)
- The Emerging Roles and Clinical Potential of Exosomes in Cancer (2018) (5)
- Metachronous Osteosarcoma: A Report of Five Cases (2003) (5)
- Expression and Clinical Implication of Autophagy-Associated Protein p62 in Osteosarcoma (2018) (5)
- High-Dose Proton Beam-Based Radiation Therapy in the Management of Extracranial Chondrosarcomas. (2016) (5)
- Angiogenesis and giant cell tumor of bone (2003) (5)
- Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value (2020) (5)
- Comparative activation response of splenocytes oxidized by periodic acid and selenium dioxide. (1983) (5)
- Is malnutrition associated with postoperative complications in patients with primary bone sarcomas? (2018) (5)
- The Use of Radiation Therapy in the Management of Selected Patients with Atypical Lipomas (2013) (5)
- Bone cancer. (2013) (4)
- Myofibroma and Myofibromatosis (2017) (4)
- Calcium is required for the mitogenic activation of lymphocytes by periodic acid oxidation. (1992) (4)
- Short-term outcomes of cementless modular endoprostheses in lower extremity reconstruction (2012) (4)
- Heterotopic Ossification After Brain and Spinal Cord Injury (1998) (4)
- Pharmacokinetics and tolerability of NSC 23925 b , a novel P-glycoprotein inhibitor : preclinical study in mice and rats (2016) (4)
- Treatment of Unresectable Osteosarcoma with Proton Therapy (2009) (4)
- Abstract B218: Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma (2009) (4)
- The use of autologous free vascularized fibula grafts in reconstruction of the mobile spine following tumor resection: surgical technique and outcomes. (2020) (4)
- Surgical management of cervical spine metastatic disease (2002) (4)
- Surgical Treatment of Metastatic Spine Disease: An Update on National Trends and Clinical Outcomes from 2010-2014. (2020) (4)
- Association between patient age and the risk of mortality following local recurrence of a sacral chordoma (2019) (4)
- What's New in Orthopaedic Oncology. (2015) (4)
- Primary arthroplasty in healed osteoarticular allograft in patients with history of primary femoral bone tumors. (2017) (4)
- Introducing and Prospective Efficacy Comparison of an Innovative and Affordable Technique for the Treatment of Distal Radius Fractures. (2019) (4)
- Prospective Phase II Study of Scanned Beam Proton Therapy for Spine Sarcomas (2018) (4)
- 206 : Proton Radiotherapy for Spine and Paraspinal Sarcomas (2006) (4)
- Enhanced protein phosphorylation, IL-2 receptor expression, and IL-2 production precede cellular proliferation in lymphocytes oxidized by periodic acid. (1989) (4)
- Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements—a statistical analysis plan (2021) (4)
- Advances in the development of chordoma models for drug discovery and precision medicine. (2022) (4)
- Bone Allograft Transplantation (2005) (4)
- Utility of Flow Cytometry in DNA Determination (2002) (4)
- Nodal involvement and survival in synovial, clear cell, angio, rhabdo, and epithelioid sarcoma. (2018) (4)
- Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma (2021) (4)
- Long-Term Effects of Connective Tissue Cancer Treatment (2004) (4)
- Proteomic profiling of chordoma (2010) (3)
- Use of an arterial tourniquet to achieve complete radiofrequency ablation of a renal metastasis. (2006) (3)
- In situ hybridization to detect DNA amplification in extracellular vesicles (2022) (3)
- Lymphoma of bone: a review of 140 patients (2006) (3)
- Interaction of cultured rat osteoblasts with 8-methoxypsoralen during irradiation with long-wave ultraviolet light. (1995) (3)
- Physical Function and Quality of Life After Resection of Mobile Spine Chondrosarcoma (2019) (3)
- Knee mass from severe metallosis after failure of a metal-backed patellar component total knee arthroplasty. (2008) (3)
- Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential. (2022) (3)
- 18F-FMISO PET/CT visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine (2014) (2)
- The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma (2015) (2)
- Intraoperative dural brachytherapy by customized iridium-192 and yttrium-90 plaques (2002) (2)
- Interleukin 2 production induced by chemically defined cell membrane modification. (1984) (2)
- Surgical management of Gorham-Stout disease of the pelvis refractory to medical and radiation therapy. (2015) (2)
- Correction to: Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation (2019) (2)
- Osteosarcoma prognostic nomograms for predicting the 10-year probability of mortality and recurrence. (2017) (2)
- Extremity liposarcoma: prognostic indicators (2007) (2)
- BH3 mimetics inhibit growth of chondrosarcoma--a novel targeted-therapy for candidate models. (2014) (2)
- Are perioperative allogeneic blood transfusions associated with 90‐days infection after operative treatment for bone metastases? (2016) (2)
- CSPG4 and B7-H3 as prognostic biomarkers in chordoma. (2010) (2)
- SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma (2022) (2)
- Abstract 3526: Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma (2010) (2)
- T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma (2020) (2)
- Aneuploidy of glandular epithelial cells in histologically normal prostate glands (1988) (2)
- ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage. (2022) (2)
- Reduction in Wound Complications With Low- Versus High-Dose Preoperative Radiation Therapy for Sacro-Coccygeal Chordomas (2013) (1)
- Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High Dose Photon/Proton Radiation Therapy (2015) (1)
- Characteristics and functional outcomes of chordoma patients admitted for inpatient rehabilitation (2018) (1)
- Pathologic discordance in sarcomas: Prospective comparison of external and sarcoma center pathologic diagnosis. (2019) (1)
- Diverse cross-resistance phenotype to Yondelis (Trabectedin; ET-743) and Zalypsis (PM00104) in paclitaxel, doxorubicin and cisplatin selected multidrug resistant cell lines (2008) (1)
- 211 : Long-Term Follow-up of Patients Treated With Neoadjuvant Chemotherapy and Radiotherapy for Large Extremity Soft-Tissue Sarcomas (2006) (1)
- Melanotic Neuroectodermal Tumor (2020) (1)
- Viability, Methods Of Assessing Leukocyte (1998) (1)
- Effects of psoralen on the structural integrity of cultured osteoblasts (2009) (1)
- Surgery of the Pelvic and Sacral Tumor (2020) (1)
- Role of Positron Emission Tomography Imaging in the Surgical Management of Peripheral Nerve Sheath Tumors in Patients with Neurofibromatosis Type 1 (2007) (1)
- Outcomes in Patients With Recurrent Desmoid Tumor Managed With Surgery Alone, Combined Surgery and Radiation Therapy, or Radiation Therapy Alone (2016) (1)
- Direct oxidation of lymphocytes by chromic acid does not induce blastogenesis (1990) (1)
- High-dose Proton-beam Based Radiation Therapy (RT) with or without Surgery in the Management of Primary and Recurrent Spine Chordomas (CH): A Retrospective Review of Outcomes and Clinicopathologic Prognostic Factors (2011) (1)
- Abstract LB-13: Hyaluronic acid-based CD44 targeted nanoparticle delivery of combination MDR1 siRNA/paclitaxel to overcome drug resistance in ovarian cancer (2014) (1)
- Effect of histone deacetylase inhibitor (HDACI) PCI-24781 on chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines. (2010) (1)
- Gene Silencing with siRNA Encapsulated Nanoparticles to Overcome Tumor Multidrug Resistance (2011) (1)
- Chordoma of the Mobile Spine: A 15-Year Experience at the Massachusetts General Hospital (2010) (1)
- Extended dermal apposition: a simple technique for the closure of irradiated perineal and sacral wounds. (2011) (1)
- A Retrospective Study of Three Surgical Treatments (2008) (1)
- A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells (2014) (1)
- Clinical Features and Pathobiology of Chordoma (2014) (1)
- Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11 (2018) (1)
- Genetic Analysis of Giant Cell Tumors of the Axial/Appendicular and Maxillofacial Skeleton (2014) (1)
- Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study (2020) (1)
- Abstract 352: Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer (2015) (1)
- Morphologic and metabolic changes in rat osteoblast cultures during the dark reaction with 8-methoxypsoralen. (1994) (1)
- Predictive Value of FMISO Positron Emission Tomography/Computed Tomography Hypoxic Subvolume for Long-Term Disease Recurrence or Metastases in Mobile Spine and Sacrococcygeal Chordoma (2016) (1)
- Low-Grade Spinal Malignancies: Chordoma and Chondrosarcoma (2020) (1)
- Imaging of pseudoneoplastic masses associated with allografts (2007) (1)
- Definitive High-Dose, Proton-Based Radiation for Unresected Mobile Spine and Sacral Chordomas (2020) (1)
- Abstract LB-102: Layer-by-layer engineering of upconversion nanoparticle based siRNA and miRNA delivery system for cancer therapy (2015) (1)
- Photon- and Proton-Beam Radiotherapy in the Treatment of Spine Tumors (2006) (1)
- Treatment Outcomes of Patients With Primary Chordomas Treated With Preoperative Radiation (Alone) Followed by Surgery (2016) (1)
- An Effective 3D Target Volume for Preoperative Radiotherapy in Extremity Soft Tissue Sarcoma and the Effect of Margin Width on Local Control (2009) (1)
- Outcomes of a Large Single Institutional Series of Radiation Associated Sarcomas (2017) (1)
- Feasibility of achieving planned surgical margins in primary spine tumor: a PTRON study. (2021) (1)
- Abstract LB-167: Phase I dose escalation study of abexinostat and doxorubicin in patients with metastatic sarcomas. (2013) (1)
- Review of Experience and Outcome of Dural Plaque Brachytherapy:2000-2013 (2014) (1)
- Percent Necrosis in Extremity Soft Tissue Sarcoma After Preoperative Radiation Alone Versus Preoperative Radiation and Chemotherapy (2007) (1)
- Clinical Characteristics and Treatment Outcomes of Radiation-Associated and Spontaneous Malignant Peripheral Nerve Sheath Tumor (2017) (0)
- Growth stimulation of human chondrocytes in primary monolayer cultures by triiothyronine (1996) (0)
- Exosomes promote pre-metastatic niche formation in ovarian cancer (2019) (0)
- Advances in the Molecular Biology of Chondrosarcoma (2021) (0)
- Adult Rhabdomyosarcoma: A Retrospective Analysis of 40 Patients Treated at a Single Institution (2016) (0)
- Cytometric and electron microscopic studies of the direct interaction of divalent nickel with intact and chemically modified HuT-78 lymphoblasts (2004) (0)
- En Bloc Resection in Combination with High Dose Radiation Improves Patient Survival in Mobile Spine Chordoma (2013) (0)
- Management of Atypical Lipomas With Radiation (2012) (0)
- Abstract 762: Prevention and reversion of multidrug resistance (MDR) in cancer by NSC23925 (2014) (0)
- High-Dose Proton Beam Boosted Radiation Therapy in the Management of Non–Skull Base Chondrosarcomas (2014) (0)
- Fibrous Cortical Defect/Nonossifying Fibroma (2017) (0)
- Chordomas and Chondrosarcomas of the Axial Skeleton (2018) (0)
- The role of extracelluar matrix in osteosarcoma progression and metastasis (2020) (0)
- Small-molecule targeting of brachyury transcription factor addiction in chordoma (2019) (0)
- Transcriptional profiling supports the notochordal origin of chordoma and its dependence on a TGFΒ1-TBXT network. (2023) (0)
- SYMPOSIUM: HIGHLIGHTS FROM THE FIRST COMBINED 2011 MEETING OF THE MUSCULO- SKELETAL TUMOR SOCIETY AND CONNECTIVE TISSUE ONCOLOGY SOCIETY Lipid-functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer (2013) (0)
- Reducing the Worldwide Burden of Cancer Oncology Expression and Clinical Implication of Autophagy-Associated Protein p 62 in Osteosarcoma (2018) (0)
- Radiation Therapy for Primary Malignant Sacral Tumors (2017) (0)
- ATR Expression as a Prognostic Biomarker and Therapeutic Target in Metastatic Osteosarcoma (2020) (0)
- Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 (HMGA2) in Osteosarcoma (2022) (0)
- Management of Soft Tissue Sarcomas (2011) (0)
- Surgical Treatment for Metastatic Lesions in Pelvis (2020) (0)
- ' s response to reviews Title : Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat 3 pathway (2010) (0)
- Patient-derived orthotopic xenograft models for osteosarcoma individualized precision treatment and effective drug discovery (2020) (0)
- Poster ViewingCombined Surgical Resection and Adjuvant High Dose Photon/Proton Radiation Therapy Strategy Results in High Local Control in Cervical Spine Chordomas (2017) (0)
- or Incompletely Resected Osteosarcoma (2011) (0)
- 205. CDDO-Me Blocks Constitutively Activated SRC/STAT3 Pathway and Inhibits Growth of Chordoma Cells (2009) (0)
- Abstract 4678: Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosis (2016) (0)
- Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma (2018) (0)
- Worse Survival in Older Adults with Rhabdomyosarcoma: Results of a Large Single Institutional Cohort (2018) (0)
- Role of Postoperative Radiation (RT) Boost for Soft Tissue Sarcomas With Positive Margins Following Preoperative RT and Resection (2013) (0)
- Multidisciplinary management of soft tissue sarcomas (1999) (0)
- Abstract 3914: High-throughput drug screening of personalized chordoma organoids: A case series of six patients (2020) (0)
- Corrigendum to "HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1" [Biochim. Biophys. Acta Mol. Basis Dis. 1864 (2018) 1839-1849]. (2020) (0)
- Treatment of giant cell tumor of bone : focus on denosumab (2018) (0)
- Variables affecting functional improvement in chordoma patients admitted to an inpatient rehabilitation facility: A retrospective review (2017) (0)
- Abstract 859: CDK11 (PITSLRE) kinase expression is critical for human cancer cell growth and proliferation (2012) (0)
- 3.P.46 HMW-MAA AND B7H3 EXPRESSION IN HUMAN CHORDOMA (2010) (0)
- Noncoding RNA in drug resistant sarcoma The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2017) (0)
- Inhibition of CDK7-Dependent Transcriptional Addiction is a Potential Therapeutic Target in Synovial Sarcoma (2022) (0)
- Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma (2017) (0)
- Secondary Leukemia and Myelodysplastic Syndrome in 375 Patients With Ewing Sarcoma and Osteosarcoma (2016) (0)
- CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 26-2016. A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar Spine. (2016) (0)
- An Approach to Recurrent Primary Osseous Tumors of the Thoracolumbar Spine (2011) (0)
- From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma (2018) (0)
- Radiation Therapy for Desmoid Tumors (2012) (0)
- Crystallization and characterization of small molecular multidrug resistance inhibitor targeting P-glycoprotein, NSC23925 isomers (2019) (0)
- Henry J. Mankin: A Trailblazer in Skeletal Pathology Research. (2020) (0)
- Analysis of the Sacral Tumor Survey and Recommendation for Future Development (2016) (0)
- Bone cancer. (2010) (0)
- Serum calcitonin in thyroid disorders and in pheochromocytoma kindred. (1986) (0)
- Abstract 3036: Comparison of miRNA expression between human osteoblasts and osteosarcoma cells (2010) (0)
- Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer (2014) (0)
- Flow cytometric enumeration of colonies for in vitro chemotherapeutic drug evaluation. (1989) (0)
- RE: local control in nonmetastatic pelvic Ewing's sarcoma patients: Outcome and analysis, by Donati, D, et al. (2007) (0)
- Resection of Periacetabular Lesions (2020) (0)
- Bone Island/Osteopoikilosis (2017) (0)
- Long-term Follow-up of Preoperative Bevacizumab and Radiation in Soft Tissue Sarcomas (2015) (0)
- Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: A 10-year follow-up study. (2012) (0)
- Circumferential Patching of the Dura Mater in the Setting of Dural Fistula after En Bloc Spondylectomy and High Dose Radiation Therapy (2015) (0)
- The roles and implications of exosomes in sarcoma (2016) (0)
- Vascular Cartilaginous Hamartoma of Chest Wall (2017) (0)
- Abstract 1732: Synthesis and evaluation of NSC23925 isomers to reverse multidrug resistance in cancer (2011) (0)
- Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment (2010) (0)
- Radiation Therapy in the Management of Acral Myxoinflammatory Fibroblastic Sarcoma (2009) (0)
- The Advances of the CRISPR/Cas9 Technology for Correcting Genetic Disorders: Using Sarcoma as a Model System (2021) (0)
- Prognostic factors in osteosarcoma: A single institution study. (2016) (0)
- Poster ViewingDifferential Oncologic Outcome in Angiosarcoma by Anatomic Subsite and Association With Prior Radiation: Implications for Prognostication and Treatment Strategy (2017) (0)
- Tissue microarray detection of is not a prognostic indicator in chordoma. (2013) (0)
- Solitary Fibrous Tumor/Hemangiopericytoma (2017) (0)
- Giants of Orthopaedic Surgery: Henry J. Mankin MD. (2019) (0)
- 175 Preoperative chemotherapy and radiation therapy for large soft tissue sarcomas: A phase II trial (1999) (0)
- Significant Risk of Secondary Malignancy In Ewing Sarcoma and Osteosarcoma Survivors (2018) (0)
- Lentiviral shRNA screen of multidrug resistant associated genes identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer (2008) (0)
- The Future of Chondrosarcoma Research and Treatment (2021) (0)
- Correction to: Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation (2019) (0)
- Dextran Nanoparticle-Based Delivery of MicroRNA ( miR ) Inhibits Growth and Proliferation of Osteosarcoma Cells (2014) (0)
- Patient-Reported Outcomes after Sacral Resection Based on the Level of Nerve Root Resection (2016) (0)
- High-Grade Surface Osteosarcoma (2017) (0)
- Clinical Study CSPG4 as a prognostic biomarker in chordoma (2016) (0)
- Phosphaturic Mesenchymal Tumor (2017) (0)
- Osteosarcoma of the Spine and Pelvis: One hundred fifteen Patients of a Single Institution (2016) (0)
- Tumors of the Sacrum: Diagnosis, Management, and Surgical Techniques (2017) (0)
- Outcomes of Patients With Synovial Sarcomas Treated With Multimodality Therapy: A Single-Institution Review (2014) (0)
- Editorial overview: Tumors and allograft associated infections (2002) (0)
- Establishment of primary cell cultures from human and canine parathyroid gland explants. (1988) (0)
- DISTAL FEMUR RECONSTRUCTIONS WITH MEGAPROSTHESES: A MULTICENTRIC STUDY OF IMPLANT SURVIVAL AND COMPLICATIONS ACCORDING TO A NEW CLASSIFICATION OF FAILURES (2012) (0)
- Updated 5-year local control (LC), metastasis-free survival (MFS), and overall survival (OS) data from a phase I study of nilotinib plus radiation (RT) in high-risk chordoma. (2020) (0)
- Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2 (2021) (0)
- Production of interleukin-1β by periodic acid-oxidized human peripheral blood mononuclear cells (1990) (0)
- Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma. (2022) (0)
- Status of Intraoperative Dural Irradiation Using Customized 90Yttrium Brachytherapeutic Plaques (2007) (0)
- Abstract 3987: Solid stress and elastic energy as measures of tumor mechanopathology (2017) (0)
- Abstract 5893: Expression and role of autophagy-associated p62 (SQSTM1) in multidrug-resistant ovarian cancer (2018) (0)
- Prognosis of Radiation Associated Bone and Soft-tissue Sarcomas (2012) (0)
- Regulates Cell Proliferation and Migration MicroRNA-199 a-3 p Is Downregulated in Human Osteosarcoma and Updated (2011) (0)
- Extremity Soft Tissue Sarcoma in Adults (2011) (0)
- Well-Differentiated Intramedullary Osteosarcoma (2017) (0)
- Abstract #905: The small molecule Tetradrine (NSC77037), identified in a high-throughput cell-based screen, reverses multidrug resistance in cancer cells (2009) (0)
- Two-Stage Total Sacrectomy (2020) (0)
- Epidermoid Inclusion Cyst (2017) (0)
- Nodal Involvement and Survival Analysis in Synovial, Clear Cell, Angio, Rhabdo, and Epithelioid(SCARE) Sarcoma (2018) (0)
- The Use of Massive Allografts in the Treatment of Knee Tumors (2004) (0)
- Characterization of genetic variants in the T gene in familial and sporadic chordoma (2013) (0)
- Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation (2019) (0)
- Optimal Management of Subcutaneous Myxofibrosarcoma: Impact of Initial Surgical Intervention on Oncologic Outcomes (2017) (0)
- Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated Osteosarcoma Compared to Spontaneous Osteosarcoma in a Large Single-Institution Series (2017) (0)
- Review of Five Institutions and a Literature Review Failure Mode Classification for Tumor Endoprostheses: Retrospective (2011) (0)
- Does RANK-L expression predict behavior of giant cell tumors? (2015) (0)
- MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma (2020) (0)
- Conditional survival of patients with nonmetastatic bone osteosarcoma. (2020) (0)
- and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats. (2016) (0)
- Faculty Opinions recommendation of Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Francis John Jr Hornicek?
Francis John Jr Hornicek is affiliated with the following schools:
